The future of AI and ML in cancer care is promising. Advances in technology will likely lead to more sophisticated and accurate diagnostic tools, more personalized treatment plans, and more effective and quicker drug discovery processes. Furthermore, the integration of AI with other emerging technologies such as genomics and wearable devices will provide a more comprehensive approach to cancer care. However, it is essential to address the ethical and regulatory issues associated with AI to ensure its responsible and effective use in healthcare.
